Trial intelligence / Profile preview

Intranasal Ketamine vs Midazolam for Pediatric Procedural Anxiolysis

NCT03043430Phase 4Terminated

Sponsor
Brooke Army Medical Center
Start
May 2016
Primary completion
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ketamine in Procedural anxiety (2 arms), sponsored by Brooke Army Medical Center. Primary endpoint: Modified Yale Preoperative Anxiety Scale. Started May 2016; status: terminated.

02

Drugs

ketamine
03

Conditions

Procedural anxiety

Beyond the preview

Go deeper on NCT03043430.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03043430.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call